the four Oslerian pathophysiological features of IE, which are still valid; therefore, they should not be discarded before the possibility of complementing them by adding standardized echocardiographic criteria is evaluated. Furthermore, it is possible that the specificity of these criteria is higher than that of the Duke criteria.
The substitution of the Duke criteria for the Beth Israel criteria should not be based solely on sensitivity. A rejection rate of just 1% raises questions about the specificity of the diagnostic categories of the Duke criteria, considering that the patients described by Hoen et al. were identified retrospectively. The specificity of both the Duke criteria and the Beth Israel criteria should be evaluated prospectively in a trial that includes bacteremic patients with suspected IE. 
